Press release – Lund, May 21st, 2026 – Monthly investor meeting on the 22nd of May when Hamlet BioPharma is releasing it’s Q3 report

Hamlet BioPharma invites you to the investors’ meeting to be held on the 22nd of May 2026, at 12:00.

Please click on the link below to participate in the meeting

https://youtube.com/live/3TgHDRRadfk?feature=share

For futher information, please contact:

Catharina Svanborg, Chairman of the Board, Hamlet BioPharma, +46-709 42 65 49
catharina.svanborg@hamletpharma.com

Jakob Testad, CEO, Hamlet BioPharma, +46-708 48 42 10
jakob.testad@hamletbiopharma.com

www.hamletbiopharma.com